Zofran Lawsuit News: Attorneys Explain Zofran Lawsuit Consolidation

Share Article

Attorneys handling national Zofran lawsuits for the Onder Law Firm provide information and commentary on the recent order by the Judicial Panel on Multidistrict Litigation to consolidate national Zofran lawsuits alleging birth defects.

The Judicial Panel on Multidistrict Litigation ruled last week that Zofran lawsuits alleging children exposed to the drug in utero have suffered birth defects have been consolidated as multidistrict litigation, according to recent court documents.* Attorneys handling national Zofran lawsuit claims provide this news update and the following commentary:

“The consolidation of national Zofran lawsuits by order of the JPML came as no surprise. These are very serious allegations made against a popular drug. Multidistrict litigation is a legal system that allows for the consolidation of complex litigation such as cases involving allegations of serious injury and wrongful death from a pharmaceutical drug or medical device. When numerous lawsuits have cropped up around the country making these same serious allegations about a particular product, consolidation is likely.

“While the initial transfer order includes only twelve cases, we expect to see many more actions transferred for pretrial proceedings. MDL is good for plaintiffs because it allows leading attorneys to join forces to build their case against a significant corporation, in this case GlaxoSmithKline. The process also expedites the resolution of these cases and prevents contradictory rulings.

“Zofran lawsuits around the country have been paused awaiting this decision from the Judicial Panel on Multidistrict Litigation. Now, it is the decision of each set of plaintiffs whether they will seek transfer or pursue their litigation individually. When a multidistrict litigation is consolidated, new cases will continue to be accepted for some time. Our firm is reviewing new cases daily for possible inclusion in the Zofran MDL.”

Zofran lawsuits have been consolidated in U.S. District Court in the District of Massachusetts, according to court documents. This location was proposed by the plaintiffs involved in the twelve initial actions, according to the Transfer Order. The defendant, GlaxoSmithKline, had proposed consolidation in the Eastern District of Pennsylvania, according to court documents.

The consolidated Zofran lawsuits share common questions of fact related to allegations that Zofran causes birth defects in children if ingested by a pregnant mother, according to court documents. The allegations range from serious injury to wrongful death, according to court documents. According to the FDA, Zofran is not approved for use in pregnant women based on the fact that no adequate safety testing has been conducted on the effects of Zofran on pregnancy.** The Zofran lawsuit claims allege GSK knew or should have known of risks to pregnant mothers and fetuses posed by Zofran use during pregnancy, yet failed to adequately warn consumers. Furthermore, the plaintiffs allege GSK knowingly promoted the drug for a variety of off-label conditions, the subject of a 2012 settlement with the U.S. Department of Justice for $3 billion, according to court documents.

These national Zofran attorneys are currently offering no-cost, no-obligation Zofran lawsuit case review for parents and families whose child was born with birth defects and was possibly exposed to Zofran during prenatal development. Individuals and families who match this description may be entitled to compensation through a Zofran lawsuit.

Nationally-renowned for groundbreaking work in drug and product safety litigation against multi-billion dollar corporations, the Onder Law Firm’s Zofran lawyers have committed their significant resources to providing expert legal representation to women, children and families who believe they may have grounds to file Zofran lawsuits. The firm provides regular Zofran lawsuit news updates at their website in order to inform the public of current pending litigation on the subject.

The Onder Law Firm welcomes Zofran lawsuit case inquiries from law firms in regards to handling them or working as co-counsel.

About The Onder Law Firm
Onder, Shelton, O’Leary & Peterson, LLC is a St. Louis based personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The pharmaceutical and medical device litigators at The Onder Law Firm have represented thousands of Americans in lawsuits against multinational conglomerates from products liability for manufacture of defective or dangerous products to deceptive advertising practices. Other firms throughout the nation often seek its experience and expertise on complex litigation. It is also a recognized leader in products liability cases such as window blind cord strangulation. The Onder Law Firm offers information from attorneys handling talcum powder lawsuits at http://www.ZofranBirthDefectsLawsuitCenter.com.

*MDL 2657, Zofran (Ondansetron) Products Liability Litigation

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Michael Gudeman
Gudeman Group
+1 314-614-8709
Email >
Follow us on